Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Additional Information (Details)

v3.23.2
Summary of Significant Accounting Policies - Additional Information (Details) - Blackstone Life Sciences
$ in Millions
 6 Months Ended
Jun. 30, 2023
USD ($)
Summary Of Significant Accounting Policies [Line Items]  
Upfront payment received $ 140.0
Maximum  
Summary Of Significant Accounting Policies [Line Items]  
Milestone payment receivable $ 250.0
Royalty | 2015 License Agreement  
Summary Of Significant Accounting Policies [Line Items]  
Revenue interest percentage 4.00%
Upfront payment received $ 140.0